Cite
[Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy].
MLA
Moreva, O. V., et al. “[Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy].” Kardiologiia, vol. 56, no. 2, Feb. 2016, pp. 40–46. EBSCOhost, https://doi.org/10.18565/cardio.2016.2.40-46.
APA
Moreva, O. V., Kropacheva, E. S., Dobrovolsky, A. B., Titaeva, E. V., & Panchenko, E. P. (2016). [Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy]. Kardiologiia, 56(2), 40–46. https://doi.org/10.18565/cardio.2016.2.40-46
Chicago
Moreva, O V, E S Kropacheva, A B Dobrovolsky, E V Titaeva, and E P Panchenko. 2016. “[Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy].” Kardiologiia 56 (2): 40–46. doi:10.18565/cardio.2016.2.40-46.